- Home
- LLYVK vs CRL Comparison
LLYVK vs CRL Comparison
Compare LLYVK & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LLYVK
- CRL
- Stock Information
- Founded
- LLYVK 1991
- CRL 1947
- Country
- LLYVK United States
- CRL United States
- Employees
- LLYVK N/A
- CRL N/A
- Industry
- LLYVK Broadcasting
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LLYVK Industrials
- CRL Health Care
- Exchange
- LLYVK Nasdaq
- CRL Nasdaq
- Market Cap
- LLYVK 7.5B
- CRL 7.3B
- IPO Year
- LLYVK N/A
- CRL 2000
- Fundamental
- Price
- LLYVK $100.44
- CRL $152.92
- Analyst Decision
- LLYVK
- CRL Buy
- Analyst Count
- LLYVK 0
- CRL 15
- Target Price
- LLYVK N/A
- CRL $186.64
- AVG Volume (30 Days)
- LLYVK 393.4K
- CRL 772.8K
- Earning Date
- LLYVK 01-01-0001
- CRL 11-05-2025
- Dividend Yield
- LLYVK N/A
- CRL N/A
- EPS Growth
- LLYVK N/A
- CRL N/A
- EPS
- LLYVK N/A
- CRL N/A
- Revenue
- LLYVK N/A
- CRL $4,028,615,000.00
- Revenue This Year
- LLYVK N/A
- CRL N/A
- Revenue Next Year
- LLYVK $11.45
- CRL $1.94
- P/E Ratio
- LLYVK N/A
- CRL N/A
- Revenue Growth
- LLYVK N/A
- CRL N/A
- 52 Week Low
- LLYVK $39.25
- CRL $91.86
- 52 Week High
- LLYVK $102.62
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- LLYVK 71.46
- CRL 41.50
- Support Level
- LLYVK $94.62
- CRL $152.18
- Resistance Level
- LLYVK $100.45
- CRL $159.78
- Average True Range (ATR)
- LLYVK 1.88
- CRL 5.87
- MACD
- LLYVK 0.05
- CRL -0.87
- Stochastic Oscillator
- LLYVK 72.75
- CRL 21.06
About LLYVK Liberty Media Corporation
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.